BrightHeart’s AI-based CHD detection platform received FDA clearance in 2024 and is currently being used at a limited range ...

Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...

BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing ...

Congenital heart defects (abnormalities of the heart that are present at birth) are the most common type of birth defect and, according to the Centers for Disease Control and Prevention, about 1 in 4 ...